
Cencora Inc., founded in 2021 and headquartered in the U.S., is a global leader in providing integrated solutions for the biopharmaceutical industry. The company focuses on advancing the commercialization of innovative therapies while offering a suite of services, including supply chain management, distribution, and logistics for biopharmaceutical products.
Bond Name | Country | Maturity | Coupon(%) | |
---|---|---|---|---|
ABC 2.70% 2031-03-15 USDCencora Inc. | United States | 2031-03-15 | 2.700 | 4.30 |
ABC 2.80% 2030-05-15 USDCencora Inc. | United States | 2030-05-15 | 2.800 | 4.15 |
ABC 2.88% 2028-05-22 EURCencora Inc. | United States | 2028-05-22 | 2.875 | 2.65 |
ABC 3.25% 2025-03-01 USDCencora Inc. | United States | 2025-03-01 | 3.250 | 32.95 |
ABC 3.45% 2027-12-15 USDCencora Inc. | United States | 2027-12-15 | 3.450 | 4.02 |
ABC 3.63% 2032-05-22 EURCencora Inc. | United States | 2032-05-22 | 3.625 | 3.44 |
ABC 4.25% 2045-03-01 USDCencora Inc. | United States | 2045-03-01 | 4.250 | 5.68 |
ABC 4.30% 2047-12-15 USDCencora Inc. | United States | 2047-12-15 | 4.300 | 5.68 |
ABC 4.63% 2027-12-15 USDCencora Inc. | United States | 2027-12-15 | 4.625 | 3.98 |
ABC 4.85% 2029-12-15 USDCencora Inc. | United States | 2029-12-15 | 4.850 | 4.16 |
ABC 5.13% 2034-02-15 USDCencora Inc. | United States | 2034-02-15 | 5.125 | 4.77 |
ABC 5.15% 2035-02-15 USDCencora Inc. | United States | 2035-02-15 | 5.150 | 4.83 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Since its inception, Cencora has strategically utilized bond issuances to fund its growth initiatives, with the first significant issuance occurring in 2022. In mid-2023, the company launched a $500 million bond offering, garnering notable attention for its competitive yield of 4.5%, significantly higher than the industry average of 3.2%. This issuance was tied to an expansion strategy, aimed at enhancing their logistical capabilities in emerging markets. Additionally, Cencora's bonds carry a unique feature of performance-linked coupons, offering investors an opportunity for incremental yield based on business milestones achieved.